Search

Search Results

• PO:07:103 | Tocilizumab use in patients with rheumatoid arthritis and malignancy: a monocentric experience Vittorio Dibenedetto^1|2|3, Nicola Farina^1|2, Nicola Boffini^1|2, Alessandro Tomelleri^1|2, Adriana Cariddi^1|2, Elena Baldissera^1|2, Marco Matucci-Cerinic^1|2|3, Lorenzo Dagna^1|2|3. | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano, Italy; ²Inflammation, Fibrosis and Ageing Intitiative ^INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; ³Vita-Salute San Raffaele University, Milano, Italy.

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2021

  68

• PO:26:088 | Rheumatologic immune-related adverse events from immune checkpoint inhibitors: a monocentric retrospective study Giulio Fraticelli^1|2, Nicola Farina^1|2, Alessandro Tomelleri^1|2, Marco Matucci Cerinic^1|2, Corrado Campochiaro^1|2, Lorenzo Dagna^1|2. | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; ²Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy.

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2065

  75

• CO:12:4 | Predicting 12-month clinical relapse in Takayasu arteritis using ^[18F]FDG PET and convolutional neural networks Alessandro Tomelleri¹, Carolina Bezzi², Sara Resta², Corrado Campochiaro¹, Federico Fallanca², Elena Baldissera¹, Samuele Ghezzo², Nicola Farina¹, Arturo Chiti², Paola Mapelli², Marco Matucci-Cerinic¹, Maria Picchio², Lorenzo Dagna¹. | ¹IRCCS Ospedale San Raffaele, Unità di Immunologia Reumatologia Allergologia e Malattie Rare, Milano; ²IRCCS Ospedale San Raffaele, Unità di Medicina Nucleare, Milano, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.1998

  84

• S13:5 | Association between vasoactive-vasodilating therapy and reduced detection of pulmonary arterial hypertension in systemic sclerosis: evidence from a European Scleroderma Trials and Research study Nicola Farina¹, Silvia Bellando-Randone¹, Sebastien Sanges², Hilde Jenssen Bjørkekjær³, Lorenzo Tofani⁴, Marie-Elise Truchetet⁵, Vanessa Smith⁶, Andra Balanescu⁷, Christina Bergmann⁸, Yannick Allanore⁹, Philipp Klemm¹⁰, Simona Truglia¹¹, Luca Idolazzi¹², Christopher Denton¹³, Roberta Foti¹⁴, Anna Wojteczek¹⁵, Emmanuel Chatelus¹⁶, Madelon Vonk¹⁷, Serena Guiducci¹, David Launay², Eric Hachulla², Jeska De Vries-Bouwstra¹⁸, Anna-Maria Hoffmann-Vold¹⁹, Oliver Distler²⁰, Marco Matucci-Cerinic¹, Cosimo Bruni¹. | ¹Department of Experimental and Clinical Medicine, Scleroderma Unit, Division of Rheumatology, University of Florence, Az, Firenze, Italy; ²Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Reference Center for Rare Autoi, Lille, France; ³Department of Rheumatology, Hospital of Southern Norway, Kristiansand, Norway; ⁴Department of Statistics, Informatics and Applications, University of Florence, Firenze, Italy; ⁵Rheumatology department, CHU de Bordeaux, Bordeaux, France; ⁶University of Ghent, Department of Rheumatology, Gent, Belgium; ⁷Department of Rheumatology, St. Maria Hospital, Carol Davila, University of Medicine and Pharmacy Bucharest Romania; ⁸Department Internal Medicine 3, University Hospital Erlangen, Erlangen, Germany; ⁹Rheumatology Department, Université Paris Cité, Cochin Hospital, Paris, France; ¹⁰Department of Rheumatology and Clinical Immunology Center, JLU Giessen, Campus Kerckhoff Bad Nauheim Germany; ¹¹Reumatologia, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma, Italy; ¹²Section of Rheumatology, Department of Medicine, University of Verona, Verona, Italy; ¹³Centre for Rheumatology, Royal Free London and University College London Medical School, London, United Kingdom; ¹⁴Division of Rheumatology, A.O.U. Policlinico-San Marco, Catania, Italy; ¹⁵Department of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Univers Gdansk Poland; ¹⁶Department of Rheumatology, University Hospital Strasbourg Strasbourg France; ¹⁷Department of rheumatology, Radboud University Nijmegen Medical Center Nijmegen The Netherlands; ¹⁸Department of Rheumatology, Leiden University Medical Center Leiden The Netherlands; ¹⁹Department of Rheumatology, Oslo University Hospital, Oslo, Norway; ²⁰Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2103

  68

• PO:19:283 | Hospitalization profile and complications in patients with adult-onset Still’s disease: results from a retrospective study of 74 cases Chiara Calabrese¹, Alessandro Tomelleri^1|2, Corrado Campochiaro^1|2, Nicola Farina², Elena Baldissera², Marco Matucci-Cerinic^1|2, Lorenzo Dagna^1|2 | ¹Libera Università Vita-Salute San Raffaele, Milano; ²Unità di Immunologia, Allergologia e malattie rare, IRCCS San Raffaele, Milano, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2172

  75